vs
SIERRA BANCORP（BSRR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是SIERRA BANCORP的1.8倍（$69.8M vs $39.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 40.4%，领先343.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 3.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 2.6%）
Sierra Bancorp是总部位于美国加利福尼亚州的地区性银行控股公司，运营Bank of the Sierra品牌，提供存款、消费贷款、商业信贷、按揭等零售及商业银行业务，主要服务加州中南部的本地社区、中小企业及个人客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BSRR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$39.3M
营收增速更快
RIGL
高出17.4%
3.8%
净利率更高
RIGL
高出343.7%
40.4%
两年增速更快
RIGL
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.3M | $69.8M |
| 净利润 | $12.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 43.6% | 33.2% |
| 净利率 | 40.4% | 384.0% |
| 营收同比 | 3.8% | 21.2% |
| 净利润同比 | 24.4% | 1769.2% |
| 每股收益（稀释后） | $0.96 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSRRRIGL
| Q4 25 | $39.3M | $69.8M | ||
| Q3 25 | $40.0M | $69.5M | ||
| Q2 25 | $39.2M | $101.7M | ||
| Q1 25 | $36.8M | $53.3M | ||
| Q4 24 | $37.9M | $57.6M | ||
| Q3 24 | $38.6M | $55.3M | ||
| Q2 24 | $37.8M | $36.8M | ||
| Q1 24 | $37.3M | $29.5M |
净利润BSRRRIGL
| Q4 25 | $12.9M | $268.1M | ||
| Q3 25 | $9.7M | $27.9M | ||
| Q2 25 | $10.6M | $59.6M | ||
| Q1 25 | $9.1M | $11.4M | ||
| Q4 24 | $10.4M | $14.3M | ||
| Q3 24 | $10.6M | $12.4M | ||
| Q2 24 | $10.3M | $-1.0M | ||
| Q1 24 | $9.3M | $-8.2M |
毛利率BSRRRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BSRRRIGL
| Q4 25 | 43.6% | 33.2% | ||
| Q3 25 | 31.7% | 40.9% | ||
| Q2 25 | 36.3% | 60.1% | ||
| Q1 25 | 33.4% | 23.9% | ||
| Q4 24 | 33.3% | 28.9% | ||
| Q3 24 | 37.4% | 25.4% | ||
| Q2 24 | 37.6% | 1.2% | ||
| Q1 24 | 33.9% | -23.6% |
净利率BSRRRIGL
| Q4 25 | 40.4% | 384.0% | ||
| Q3 25 | 24.2% | 40.2% | ||
| Q2 25 | 27.1% | 58.6% | ||
| Q1 25 | 24.8% | 21.5% | ||
| Q4 24 | 34.1% | 24.9% | ||
| Q3 24 | 27.5% | 22.5% | ||
| Q2 24 | 27.2% | -2.8% | ||
| Q1 24 | 25.0% | -27.9% |
每股收益（稀释后）BSRRRIGL
| Q4 25 | $0.96 | $14.11 | ||
| Q3 25 | $0.72 | $1.46 | ||
| Q2 25 | $0.78 | $3.28 | ||
| Q1 25 | $0.65 | $0.63 | ||
| Q4 24 | $0.73 | $0.82 | ||
| Q3 24 | $0.74 | $0.70 | ||
| Q2 24 | $0.71 | $-0.06 | ||
| Q1 24 | $0.64 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $135.6M | $155.0M |
| 总债务越低越好 | $49.5M | $52.5M |
| 股东权益账面价值 | $364.9M | $391.5M |
| 总资产 | $3.8B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.14× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BSRRRIGL
| Q4 25 | $135.6M | $155.0M | ||
| Q3 25 | $95.5M | $137.1M | ||
| Q2 25 | $130.0M | $108.4M | ||
| Q1 25 | $159.7M | $77.1M | ||
| Q4 24 | $100.7M | $77.3M | ||
| Q3 24 | $132.8M | $61.1M | ||
| Q2 24 | $184.0M | $49.1M | ||
| Q1 24 | $119.2M | $49.5M |
总债务BSRRRIGL
| Q4 25 | $49.5M | $52.5M | ||
| Q3 25 | $49.5M | $60.0M | ||
| Q2 25 | $49.4M | $60.0M | ||
| Q1 25 | $49.4M | $60.0M | ||
| Q4 24 | $49.4M | $60.0M | ||
| Q3 24 | $49.4M | $60.0M | ||
| Q2 24 | $49.3M | $60.0M | ||
| Q1 24 | $49.3M | $60.0M |
股东权益BSRRRIGL
| Q4 25 | $364.9M | $391.5M | ||
| Q3 25 | $360.1M | $117.6M | ||
| Q2 25 | $355.7M | $81.9M | ||
| Q1 25 | $351.8M | $18.6M | ||
| Q4 24 | $357.3M | $3.3M | ||
| Q3 24 | $358.7M | $-14.6M | ||
| Q2 24 | $350.0M | $-29.9M | ||
| Q1 24 | $345.1M | $-31.7M |
总资产BSRRRIGL
| Q4 25 | $3.8B | $513.6M | ||
| Q3 25 | $3.7B | $242.5M | ||
| Q2 25 | $3.8B | $206.7M | ||
| Q1 25 | $3.6B | $176.0M | ||
| Q4 24 | $3.6B | $164.0M | ||
| Q3 24 | $3.7B | $139.4M | ||
| Q2 24 | $3.7B | $128.4M | ||
| Q1 24 | $3.6B | $126.5M |
负债/权益比BSRRRIGL
| Q4 25 | 0.14× | 0.13× | ||
| Q3 25 | 0.14× | 0.51× | ||
| Q2 25 | 0.14× | 0.73× | ||
| Q1 25 | 0.14× | 3.23× | ||
| Q4 24 | 0.14× | 18.25× | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $32.2M | — |
| 自由现金流率自由现金流/营收 | 81.9% | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | 2.61× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $50.8M | — |
8季度趋势，按日历期对齐
经营现金流BSRRRIGL
| Q4 25 | $33.7M | $22.0M | ||
| Q3 25 | $14.9M | $24.0M | ||
| Q2 25 | $-35.9M | $30.5M | ||
| Q1 25 | $40.6M | $-893.0K | ||
| Q4 24 | $57.2M | $14.5M | ||
| Q3 24 | $27.4M | $21.7M | ||
| Q2 24 | $620.0K | $302.0K | ||
| Q1 24 | $7.0M | $-5.0M |
自由现金流BSRRRIGL
| Q4 25 | $32.2M | — | ||
| Q3 25 | $14.7M | — | ||
| Q2 25 | $-36.3M | — | ||
| Q1 25 | $40.2M | — | ||
| Q4 24 | $56.0M | — | ||
| Q3 24 | $27.3M | — | ||
| Q2 24 | $202.0K | — | ||
| Q1 24 | $6.6M | — |
自由现金流率BSRRRIGL
| Q4 25 | 81.9% | — | ||
| Q3 25 | 36.7% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | 109.5% | — | ||
| Q4 24 | 147.9% | — | ||
| Q3 24 | 70.7% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 17.7% | — |
资本支出强度BSRRRIGL
| Q4 25 | 3.9% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.0% | — |
现金转化率BSRRRIGL
| Q4 25 | 2.61× | 0.08× | ||
| Q3 25 | 1.54× | 0.86× | ||
| Q2 25 | -3.37× | 0.51× | ||
| Q1 25 | 4.46× | -0.08× | ||
| Q4 24 | 5.51× | 1.01× | ||
| Q3 24 | 2.58× | 1.75× | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
